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Abstract: The status of comatose patient is currently established on the basis of the patient-exhibited 
behaviors. Clinical assessment is subjective and, in 40% of patients, fails to distinguish vegetative state 
(VS) from minimally conscious states (MCS). The technologic advances of magnetic resonance imaging 
(MRI) have dramatically improved our understanding of these altered states of consciousness. The role of 
neuroimaging in coma survivors has increased beyond the simple evaluation of morphological 
abnormalities. The development of 1H-MR spectroscopy (MRS) and diffusion tensor imaging (DTI) 
provide opportunity to evaluate processes that cannot be approached by current morphologic MRI 
sequences. They offer potentially unique insights into the histopathology of VS and MCS. The MRS is a 
powerful noninvasive imaging technique that enables the in vivo quantiﬁcation of certain chemical 
compound or metabolites as N-acetylaspartate (NAA), Choline (Cho), and Creatine (Cr). These 
biomarkers explore neuronal integrity (NAA), cell membrane turnover (Cho), and cell energetic function 
(Cr). DTI is an effective and proved quantitative method for evaluating tissue integrity at microscopic 
level. It provides information about the microstructure and the architecture of tissues, especially the white 
matter. Various physical parameters can be extracted from this sequence: the fractional anisotropy (FA), 
a marker of white matter integrity; mean diffusivity (MD); and the apparent diffusion coefﬁcient (ADC) 
which can differentiate cytotoxic and vasogenic edema. The most prominent ﬁndings with MRS and DTI 
performed in traumatic brain-injured (TBI) patients in subacute phase are the reduction of the NAA/Cr 
ratio in posterior pons and the decrease of mean infratentorial and supratentorial FA except in posterior 
pons that enables to predict unfavorable outcome at 1 year from TBI with up to 86% sensitivity and 97% 
speciﬁcity. This review will focus on the interest of comatose patients MRI multimodal assessment with 
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MRS and DTI. It will emphasize the advantages and pitfalls of these techniques in particular in predicting 
the coma survivors’ outcome. 
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Introduction
Survivors of severe brain damage following 
traumatic brain injury (TBI), stroke, or anoxic/ 
hypoxic encephalopathy may remain in an altered 
state of consciousness during several years. 
TBI is the most frequent etiology of severe brain 
damage among young and middle-aged adults (as 
compared to stroke and tumors in elderly 
subjects; Katz, 1997), leading to up to 14% of 
subsequently permanently vegetative patients 
(Celesia, 1993; Jennett, 2005; Payne et al., 1996). 
However, in about 5–10% of these TBI patients, 
anatomical lesions detected by classical morpho­
logical MRI (sequences such as T2�, FLAIR, and 
diffusion) are unable to explain their clinical 
status and to give clue about their chance of 
recovery. These patients present signiﬁcant pro­
blems concerning diagnosis and misdiagnosis, 
prognosis, and therapy (Andrews et al., 1996; 
Childs and Mercer, 1996; Schnakers et al., 2009). 
The announcement of an optimistic outcome will 
increase the commitment of the team, while a 
pessimistic prognosis risks demobilizing and jeo­
pardizing the potential recovery of the patient. 
Questions about end of life, aggressive therapy, 
limitation of care, and euthanasia often arise in 
such cases and lead to passionate debates among 
the medical staff, and sometimes more widely in 
the media and society. Therefore, neuroimaging 
techniques should be used not only to evaluate 
structural abnormality and detect TBI complica­
tions but also to reliably show the extent of brain 
damage in a clinical diagnostic and a therapeutic 
way and lead to a better understanding of the 
behavioral observations. In this review, we discuss 
recent developments in the use of proton mag­
netic resonance spectroscopy (MRS) and diffu­
sion tensor imaging (DTI) in the assessment of 
brain injury patients in particular after TBI due to 
the frequency of this etiology. 
Imaging protocols
Magnetic resonance imaging (MRI) in coma 
survivors is routinely performed on 1.5 T or 3 T 
MR scanners. MRI assessment may often be 
limited by patient motion which can necessitate 
sedation; the risk of uncontrolled intracranial 
pressure occurring during the exam if performed 
when brain swelling is still present; unstable 
hemodynamic or respiratory condition, due to the 
limited monitoring available in the magnet; and 
artifacts generated by some metallic devices (most 
commonly intracranial pressure valves). In our 
view, a comprehensive patient MRI exploration 
should check both infra- and supratentorial 
structures, involved in arousal and awareness 
functions (Boly et al., 2008b). The ascending 
reticular activating system, located in the poster­
ior part of the upper two-thirds of the brainstem 
is the primary arousal structure (Parvizi and 
Damasio, 2001; Plum and Posner, 1980). The 
evaluation of the patient’s brain ability to 
generate awareness should include the assessment 
of the integrity of a large set of supratentorial 
structures, encompassing thalamus, basal fore­
brain, and fronto-parietal association cortices 
(Laureys et al., 1999; Parvizi and Damasio, 2001; 
Selden et al., 1998). 
Classical morphological MRI was shown to 
poorly correlate with recovery of consciousness in 
severely brain-damaged patients. The fact that 
patients often develop progressive posttraumatic 
global brain atrophy (Table 1), despite the fact 
that initial morphologic imaging revealed only 
discrete ﬁndings or failed to show any pathology, 
also reﬂects the insufﬁciency of conventional 
imaging techniques to comprehensively evaluate 
the gravity of brain lesion in individual patients 
(Anderson et al., 1996; Gale et al., 1995; Gentry 
et al., 1988; Kelly et al., 1988). In particular, 
morphological MRI is not accurate for diagnosis 
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Table 1. Prognosis values of structural magnetic resonance imaging, magnetic resonance spectroscopy, diffusion weighted imaging 
and diffusion tensor imaging in altered state of consciousness patients 
Authors Number of Diagnosis Etiology Interval Main ﬁndings 
patients 
Structural magnetic resonance imaging
Firsching et al. (1998) 61 
Kampﬂ et al. (1998) 80 
Paterakis et al. (2000) 24 
Carpentier et al. (2006) 40 
Magnetic resonance spectroscopy
Choe et al. (1995) 10 
Friedman et al. (1999) 14 
Garnett et al. (2000) 26 
Sinson et al. (2001) 30 
Uzan et al. (2003) 14 
Carpentier et al. (2006) 40 
Marino et al. (2007) 10 
Coma; CGSr7 TBI 
(n ¼ 61) 
Vegetative state; TBI 
CGSr8 (n ¼ 80) 
Severe head injury; TBI 
GCSo8 (n ¼ 19); 
Moderate head 
injury; GCS 9–12 
(n ¼ 5) 
Severe TBI; GCS TBI 
673 (n ¼ 40) 
Closed head injury; TBI 
GCS 3–12 (n ¼ 10) 
TBI; GCS 3–8 TBI 
(n ¼ 7), GCS 9–14 
(n ¼ 5), GCS NA 
(n ¼ 2) 
TBI; GCS 3–8 TBI 
(n ¼ 9), GCS 9–15 
(n ¼ 17) 
TBI; GCS 3–15 TBI 
(n ¼ 30) 
Vegetative state; TBI 
GCS 4–7 (n ¼ 14) 
Severe TBI; GCS TBI 
673 (n ¼ 40) 
TBI; GCS 4–7 TBI 
(n ¼ 7), GCS 8–13 
(n ¼ 3) 
o7 d 






12 d, range 
3–35 





100% of mortality with bilateral pontine 
lesion, 2% with no brainstem lesion, 8% 
with unilateral or midline mesencephalon 
lesion, 8% with unilateral pons or medulla 
oblongata lesion, and 0% with lesion of the 
lower bilateral portions of medulla 
oblongata 
214-fold higher probability for not 
recovering with lesions in the corpus 
callosum and 7-fold with dorsolateral 
brainstem lesion 
Good recovery when hemorrhagic DAI 
lesions; unfavorable outcome not 
associated with isolated nonhemorrhagic 
DAI lesions; 100% of unfavorable outcome 
when subcortical gray matter injury; 
subarachnoid hemorrhage not associated 
with favorable and unfavorable outcome 
Number of brainstem lesions: 4.373.3 for 
patients with GOS ¼ 1–2, 1.971.5 for 
GOS ¼ 3, 0.571.1 for GOS ¼ 4–5 
Fronto-parietal white matter: positive 
correlation of NAA/Cr ratio with 
emergence of vegetative state 
Occipito-parietal white and gray matter: 
patients with decreased NAA 
concentration have poor overall cognitive 
function at outcome 
Frontal white matter: GOS correlated with 
NAA/Cr (r ¼ 0.65) and NAA/Cho ratio 
(r ¼ 0.58); GOS did not correlate with Cho/ 
Cr and Ins/Cr 
Splenium: NAA/Cr ratio signiﬁcantly lower 
in patients with rGOS ¼ 1–4 (1.2470.28 
NAA/Cr ratio) than GOS ¼ 5 (1.5370.37 
NAA/Cr ratio) 
Thalamus: lower NAA/Cr ratio in 
permanent vegetative patients (1.1770.25) 
than patients who recovered (1.870.26, 
po0.001); Cho/Cr ratio did not permit 
outcome differentiation 
Brainstem: NAA/Cr ratio showed 
signiﬁcant difference between patients with 
GOS ¼ 1–2 (1.6870.4 NAA/Cr ratio) and 
GOS ¼ 4–5 (2.170.3 NAA/Cr ratio) 
Central brain: correlation of GOS with 
NAA (r ¼ �0.79) and La ratio (r ¼ 0.79) 
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Table 1. (Continued ) 
Authors Number of Diagnosis Etiology Interval Main ﬁndings 
patients 
Tollard et al. (2009) 43 Closed-head injury, TBI 24711 d Thalamus, lenticular nucleus, insular 
GCSr7 (n ¼ 43) cortical gray matter, occipital white matter: 
NAA/Cr values at all sites lowest in 
patients with GOS ¼ 1–3 (1.370.3 NAA/ 
Cr ratio) than with GOS ¼ 4–5 (1.770.4 
NAA/Cr ratio) 
Diffusion weighted imaging
Schaefer (2004) 26 Closed head injury; TBI o48 h Correlation between number of lesions and 
GCS 1073 (n ¼ 26) outcome (r ¼ 0.662); corpus callosum and 
outcome (r ¼ 0.513); brainstem lesion and 
outcome (r ¼ 0.316); basal ganglia/ 
thalamus and outcome (r ¼ 0.179) 
Diffusion tensor imaging
Huisman et al. (2004) 20 Head traumatic TBI o7 d Splenium: correlation between outcome 
injury; GCS 974 and ADC (r ¼ �0.599), and outcome and 
(n ¼ 20) FA (r ¼ �0.694); internal capsule: 
correlation between outcome and FA 
(r ¼ �0.714), no correlation between 
outcome and ADC (r ¼ �0.018); thalamus/ 
putamen: no correlation between outcome 
and FA and ADC 
Tollard et al. (2009 43 Closed head injury; TBI 24711 d Pons, midbrain, temporal and occipital 
GCSr7 (n ¼ 43) white matter, internal and external 
capsules, semioval center: FA signiﬁcantly 
lower in patients with GOS 1–3 than with 
GOS 4–5 patients, except in the posterior 
pons; 86% sensitivity and 97% speciﬁcity 
for predicting outcome by combining MRS 
and DTI analysis 
Perlbarg et al. (2009) 30 TBI with persistent TBI 24711 d FA signiﬁcantly lower in GOS 1–3 than in 
disorder of GOS 4–5 and controls in right inferior 
consciousness; GCS longitudinal fasciculus, right cerebral 
674 (n ¼ 30) peduncle, right posterior limb of the 
internal capsule and posterior corpus 
callosum 
Notes: GCS, Glasgow Coma Scale; TBI, traumatic brain injury; NA, not available; d, days; h, hours; DAI, diffuse axonal injury; NAA, 
N-acetylaspartate; Cr, creatinine; Cho, choline; Ins, myo-inositol; GOS, Glasgow Outcome Scale; La, lactate; ADC, apparent diffusion coefﬁcient; 
FA, fractional anisotropy. 
or assessment of severity and extension of diffuse 
axonal injury (DAI). DAI consists in diffuse white 
matter damage, usually caused by the effect of 
brutal acceleration–deceleration and/or rotational 
forces; resulting in stretching, disruption, and 
separation of axons as the brain moves inside the 
skull and causing important morbidity and mor­
tality (Adams et al., 1982; Strich, 1961; Gean, 
1994; Murray et al., 1996). Morphological MRI 
assessments were however shown to be more 
sensitive and speciﬁc to assess the recovery of 
consciousness than computed tomodensitometry 
and electrophysiological tools (Wedekind et al., 
1999). 
Taking into account these considerations, con­
ventional MRI cannot be considered as a reliable 
technique to assess brain-injured patients and 
predict their functional outcome. The lack of 
sensitivity of conventional MRI led to introduce 
new tools in the clinical assessment of comatose 
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Fig. 1. Axial ﬂuid attenuated inversion recovery (FLAIR) (left) and T2� (right) in a TBI minimally conscious patient. T2� sequence 
shows hyposignal in the midbrain suggestive of bleeding not clearly seen on FLAIR sequence. 
patients such as positron emission tomography 
(PET; Beuthien-Baumann et al., 2003; Boly et al., 
2008a; Laureys et al., 1999), functional MRI 
(fMRI; Boly et al., 2008b, Monti et al., 2009; 
Coleman et al., 2007; Owen et al., 2006), MRS 
(Cox, 1996), and DTI (Assaf and Pasternak, 2008; 
Voss et al. 2006). Preliminary studies suggest that 
these alternative functional and metabolic ima­
ging methods could be more sensitive to detect 
brain damage immediately following TBI, and 
could thus be useful to monitoring longitudinal 
changes in brain function of non-communicative 
brain-damaged patients. In the future, they could 
play a crucial role in coma assessment, adding to 
a purely morphology-based imaging approach a 
more comprehensive evaluation of the patient’s 
brain ability to generate consciousness, combining 
information on structure and function. 
Conventional MRI protocol
In our view, in order to perform a comprehensive 
assessment of structural damage in individual 
coma patients, the morphologic MRI acquisitions 
should include noncontrast-enhanced sagittal T1, 
axial ﬂuid attenuated inversion recovery 
(FLAIR), axial T2�, axial diffusion, coronal T2 
sequences, and a 3D T1 weighted volume 
acquisition. In our centers, images are typically 
obtained with a section thickness of 5 mm (except 
for the 3D T1 which is millimetric). FLAIR 
sequence detects brain edema and contusion, 
epidural or subdural hematoma, subarachnoid 
hemorrhage, as well as the resulting herniation 
or hydrocephalus; while gradient echo-planar T2�
weighted images are useful in detecting hemor­
rhage (Gerber et al., 2004; Scheid et al., 2003) 
(Fig. 1). The 3D T1 sequence provides informa­
tion on the volume of the brain, and can be use 
during the follow up of patients. Indeed, severe 
and irreversible brain damage would lead to 
progressive brain atrophy, over a period of weeks 
to years (Trivedi et al., 2007). 
Diffusion tensor imaging protocol
DTI is one of the most popular MRI techniques 
investigated in current brain-imaging research 
(Fig. 2). It is an extension of diffusion-weighted 
imaging (DWI) which is based on the principle 
that water molecule movement is restricted by 
barriers to diffusion in the brain depending on 
tissue organization. The acquisition protocol, 
image processing, analysis, and interpretation of 
DTI are now routinely performed in clinical 
conditions although it suffers from inherent 
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Fig. 2. Example of diffusion tensor imaging (DTI) obtained in a healthy volunteer, visualising the white matter tracts. Acquisition 
time: 4:51; TR/TE: 5700/90 ms; Resolution: 128 � 128; Slices: 40 transversal slices (2.0 mm thickness, 30% gap, interleaved); Voxel 
size: 1.8 � 1.8 � 2.0 mm3; FoV: 230 � 230 mm2. 
artifacts and limitations such as the partial volume 
effect and the inability of the model to cope with 
non-Gaussian diffusion. DTI imaging is classically 
performed in axial plane, using the following 
parameters: TR/TE, 8000/84.9 ms; 23 directions; 
diffusion b value, 700 s/mm2; slice thickness, 5 mm; 
no gap; 20 slices; ﬁeld of view, 32 � 32 cm; matrix, 
128 � 128; and 2 averages (Tollard et al., 2009). 
DTI provides data that can be used to compute 
two basic properties: the overall amount of 
diffusion represented by the apparent diffusion 
coefﬁcient (ADC) and the fractional anisotropy 
(FA) which enable visualization and characteriza­
tion of white matter (WM) in two and three 
dimensions. The FA characterizes the anisotropic 
component, that is, degree and directionality of 
water diffusion. Determination of FA allows a 
quantiﬁcation of WM density in vivo and gives 
information about its integrity (Liu 
et al., 1999; Melhem et al., 2000; Pierpaoli et al., 
1996). In our protocol of data acquisition and 
analysis, symmetric rectangular regions of interest 
(ROI) are also used for the quantitative measures 
positioning at several sites including the anterior 
and posterior pons, right and left midbrain, the 
right and left WM of temporal lobe, occipital lobe, 
posterior limb of the internal capsule, external 
capsule, anterior and posterior semiovale centrum 
(Tollard et al., 2009). 
DWI and DTI show anomalies invisible on 
current morphological MRI even on T2�
sequence (Huisman et al., 2003) and can better 
assess the degree of neurological impairment 
than any other conventional MRI sequence 
(Shanmuganathan et al., 2004). DTI permits to 
identify speciﬁc ﬁber bundles such as the corpus 
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callosum and the long association ﬁbers that 
include cingulum, superior and inferior long­
itudinal fascicules, uncinate fasciculus, superior 
and inferior fronto-occipital fascicules. Other 
ﬁbers bundles can also be visualized: brainstem 
tracts, projection ﬁbers such as corticospinal and 
corticothalamic ﬁbers. DTI is an appropriate 
technique to assess microstructural WM damage 
that occurs in TBI, particularly since the patho­
physiological mechanisms altering water diffusion 
anisotropy include DAI and intracranial hyper­
tension. Several studies conﬁrmed that DWI is a 
valuable technique to assess DAI (Arfanakis 
et al., 2002; Huisman et al., 2003; Liu et al., 
1999) and showed that DTI is sensitive to 
damage in tissue that may appear normal on 
conventional MRI sequences (Arfanakis et al., 
2002; Chan et al., 2003). Over conventional 
sequences commonly used to assess DAI (such 
as FLAIR, T2�, diffusion-weighted, and suscept­
ibility weighted), DTI offers the advantages of a 
greater sensitivity and the availability of quanti­
tative information. 
Magnetic resonance spectroscopy protocol
MRS provides in vivo biochemical information. 
The metabolites that can be identiﬁed with proton 
MRS are dependent on the echo time (TE). At 
1.5 T and 3 T, metabolites visualized utilizing 
intermediate-to-long TE (135–288 ms) include 
choline (Cho), creatine (Cr), N-acetylaspartate 
(NAA), and lactate (La). NAA is produced in the 
mitochondria of the neurons and transported into 
the neuronal cytoplasm and the axons. It is found 
in both gray and white matter in approximately 
equal quantities (Danielsen and Ross, 1999). In 
healthy subjects, there is an increase in NAA in 
gray matter from ventral to dorsal, and from 
the cerebral hemispheres to the spinal cord 
(Pouwels and Frahm, 1998). Several studies 
suggest NAA to be a brain osmolyte with possible 
reversible changes (Baslow et al., 2003, 2007; 
Moffett et al., 2007). It is considered as a marker 
of neuronal density and viability and functional 
status (Ebisu et al., 1994; Sullivan et al., 2001); 
its peak decrease when there is neuron suffering 
or loss. Choline is a metabolic marker of 
membrane synthesis and catabolism. MRS per­
mits to detect free choline and phosphocholine, 
that is, those that are not incorporated into 
the macromolecules on the membrane surface 
(Ross and Michaelis, 1994). Its concentration is 
slightly greater in white than in gray matter. Its 
peak increases when there is greater membrane 
turnover, cell proliferation, or inﬂammatory pro­
cess. Creatine is considered as a marker of the 
aerobic energy metabolism. It is assumed to be 
stable, hence is used for calculating metabolite 
ratios (NAA/Cr and Cho/Cr ratios). Lactate is 
at the limit of detectability in normal human 
brain using the routine spectroscopic techniques. 
However, under anaerobic glycolysis conditions, 
such as brain hypoxia, ischemia, or severe post­
traumatic injury, lactate level may increase 
signiﬁcantly. 
In our view, a comprehensive MRS protocol to 
assess brain function in comatose patients should 
include single-voxel 1H spectroscopy (SVS) 
placed on the posterior two-thirds of the pons 
(the parameters we typically use are: TR/TE, 
1500/135 ms; matrix, 1 � 1; voxel thickness, 20 mm; 
and 96 averages) (Fig. 3) and an axial chemical 
shift imaging (CSI) at the level of the basal 
ganglia to include thalamus, insular cortex, and 
periventricular WM in the ﬁeld of exploration 
(the parameters we typically use are: TR/TE, 
1500/135 ms; ﬁeld of view, 24 � 24 cm; matrix, 
18 � 18; slice thickness, 15 mm; and NEX, 1) 
(Tollard et al., 2009) (Fig. 4). In our clinical 
practice, the SVS is usually performed in the 
pons for three reasons. First, the pons contains a 
large part of the ascending reticular activating 
system; second, the pons is often affected by DAIs 
not necessarily seen on FLAIR and T2�
sequences; and third, the pons can be damaged 
from both primary and secondary cerebral 
injuries due to temporal lobe herniation 
(Carpentier et al., 2006). Patients with bilateral 
lesions of the protuberance on standard morpho­
logical MRI sequences have been reported with 
a 100% mortality rate (Firsching et al., 1998). 
Finally, MRS has a better sensitivity than 
T2�sequence in the detection of ischemic or 
hemorrhagic diffuse axonal lesions in TBI (Cecil 
et al., 1998). 
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Fig. 3. Monovoxel spectroscopic (SVS) of the pons in a TBI patient. a: Location of the voxel on the sagittal T1-weighted acquisition. 
b: Decreased NAA spectrum (NAA/Cr ¼ 0.90 and NAA/Cho+Cr+NAA ¼ 0.29). 
Comatose patients assessment
The timing of an optimal MRI assessment in 
comatose patients remains controversial (Table 1). 
An acute exploration may take into account 
reversible lesions such as edema or miss secondary 
lesions due to intracranial hypertension or sys­
temic disorders. On the contrary, an examination 
performed late after the injury may only detect 
sequels such as global aspeciﬁc atrophy and has no 
impact on the initial medical management and on 
altered state of consciousness status prediction. 
With regard to time since TBI or stroke, MRS and 
DTI ﬁndings vary greatly and studies are hetero­
geneous as illustrated by last studies performed 
with MRS sequences. Four phases may be 
distinguished: an acute phase, which lasts 24 h 
after TBI; an early subacute phase, from the day 1 
to 13; a late subacute phase, from days 14 to 20; 
and a chronic phase, which starts on day 21 (Weiss 
et al., 2007). Among these MRS studies, two 
included patients at the acute phase (Marino et al., 
2007; Ross et al., 1998), two from the early 
subacute phase to the ﬁrst month (Carpentier 
et al., 2006; Garnett et al., 2000), one at the late 
subacute phase up to 11 months (Choe et al., 
1995), and four at the chronic phase from 3 weeks 
to 8 months after TBI (Friedman et al., 1999; Ricci 
et al., 1997; Sinson et al., 2001; Uzan et al., 2003). 
In a retrospective study using DTI, comatose 
patients were excluded if the time delay between 
trauma and MRI exceeded 7 days to avoid the 
various changes in anisotropic diffusion related to 
secondary tissue injury (Huisman et al., 2004). An 
early examination with precise quantiﬁcation of 
the extent and degree of brain injury is essential 
for treatment decisions (i.e., to determine out­
come, cognitive and behavioral deﬁcits), and 
becomes a criterion of good practice in manage­
ment of these patients. The late subacute phase 
seems to be the best moment to assess comatose 
patients taking into account the physiopathology 
and all issues (medical, ethical, legal, social) raised 
by the management of these patients. 
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Fig. 4. Chemical shift imaging (CSI). Position of regions of interest: insula (1), lenticular nucleus (2), thalamus (3), and 
periventricular white matter (4). 
Prediction of outcome with MRI
Although clinical examination and conventional 
imaging techniques provide useful information for 
TBI patient screening and acute care, none of 
them accurately predicts individual patient out­
come. Developing a reliable MRI outcome-
prediction tool is a major challenge for all 
physicians in charge of comatose patients. It 
would provide an objective basis for deciding to 
go on with prolonged aggressive care or to 
remove life-supporting therapy as well as for 
informing families and planning rehabilitation. 
Conventional MRI
There is some evidence that MRI may have 
potential in terms of predicting outcome accord­
ing to several studies performed with conven­
tional MRI. Firsching and colleagues (1998) 
performed a prospective MRI study in 61 con­
secutive patients within 7 days after their injury. 
They found bilateral pontine lesions to be 100% 
fatal, whereas unilateral brainstem lesions were 
responsible of similar mortality rate as in patients 
with no brainstem injury and conclude that early 
MRI after head injury had a higher predictive 
value than CT scanning. Other studies have 
showed that MRI scans performed at acute and 
subacute phase after head injury provide several 
indicators for unfavorable outcome when there 
are lesions within the corpus callosum and 
dorsolateral brainstem (Kampﬂ et al.,1998), 
basal ganglia, hippocampus, midbrain, and pons 
(Wedekind et al., 1999). Presence of hemorrhage 
in DAI-type lesions and the association with 
traumatic space-occupying lesions was indicative 
of poor prognostic sign. Isolated non-hemorrhagic 
DAI-type lesions were not associated with poor 
clinical outcome (Paterakis et al., 2000). Hoelper 
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et al. (2000) observed that the number (W3) and 
volume (W1.5 mL) of brainstem lesions correlated 
with unfavorable outcome. There are also some 
evidences that the total lesion volume on FLAIR 
images correlates signiﬁcantly with clinical out­
come. The volume of lesions of the corpus 
callosum on the FLAIR sequence correlated 
signiﬁcantly with scores on disability and cogni­
tion scales at the ﬁrst clinical assessment. Volume 
of FLAIR lesions in the frontal lobes correlated 
signiﬁcantly with outcome after 1 year (Pierallini 
et al., 2000). Moreover, the number of lesions 
detected by T2� was also shown as signiﬁcantly 
greater than that detected by T2-FSE (Yanagawa 
et al., 2000). Lesions detected by T2� and FLAIR 
were inversely correlated with outcome of patient 
(Yanagawa et al., 2000; Carpentier et al., 2006). 
In spite of these multiple morphological MRI 
studies and their encouraging results (Table 1), it 
remains difﬁcult to explain why some patients in 
persistent vegetative state or with long-term 
marked cognitive impairments have no or mini­
mal lesions on conventional MR examination 
performed with T2� and diffusion sequences. 
Therefore, morphological MRI alone cannot be 
considered as a reliable tool to assess coma 
severity, and to predict the comatose patient 
functional outcome. 
Magnetic resonance spectroscopy
To our knowledge, Choe et al. (1995) performed 
the ﬁrst assessment of patient with closed head 
injury using in vivo proton MRS to evaluate 
neuronal and axonal dysfunction. The main result 
in this case-control study was a signiﬁcant 
decrease of NAA/Cr ratio compared with normal 
controls. The level of NAA/Cr ratio was signiﬁ­
cantly correlated with Glasgow Outcome Scale 
(GOS; Jennett and Bond, 1975) whereas no clear 
correlation of other metabolite ratios such as 
Cho/Cr was observed. Since then, several inves­
tigations that do appear in the literature were 
promising in terms of the role of proton MRS as 
an accurate tool to predict patient outcome. Ricci 
et al. (1997) examined 14 vegetative brain-injured 
patients with proton magnetic resonance single-
volume spectroscopy performed 1–90 months 
after the injury. Cho/Cr was signiﬁcantly higher, 
whereas NAA/Cho and NAA/Cr were markedly 
lower than in the control subjects. The NAA/Cho 
ratio was statistically signiﬁcant in discriminating 
between the patients with a poor outcome (GOS 
score, 1–2) and those who regained awareness. 
Other studies have showed a reduced NAA/Cr 
level in gray and white matter of occipito-parietal 
regions in acute and subacute phase after injury, 
which correlated with bad outcome (Ross et al., 
1998; Friedman et al., 1999). The frontal WM 
NAA/Cr acquired in the subacute phase signiﬁ­
cantly correlated with patient outcome, whereas 
Cho/Cr was increased at both the early and late 
phase compared with controls (Garnett et al., 
2000). Decreased NAA/Cr ratio in the splenium 
of corpus callosum also correlated with the GOS 
score of acute and chronic patients (Sinson et al., 
2001). The NAA/Cr ratio was reduced in the 
thalami of both persistent vegetative patients and 
patients who recovered 6–8 months after injury 
(Uzan et al., 2003). Moreover, NAA/Cr ratios 
were lower in persistent vegetative patient than in 
patients who regained awareness. Carpentier 
et al. (2006) observed three MRS proﬁle of the 
pons after TBI: normal proﬁle (the peak of NAA 
is higher than the peaks of Cho and Cr), neuronal 
loss proﬁle (the NAA peak is decreased, nearly to 
the level of the Cr peak; the NAA/Cr ratio is 
o1.50 and NAA/Cho+Cr+NAAo0.40) (Fig. 3), 
and gliosis proﬁle (increased Cho peak with no 
change in the Cr or NAA peak and Cho/ 
CrWNAA/Cr or Cho/Cho+Cr+NAAW0.40). 
The NAA/Cr ratio was correlated with the 
GOS score but not with lesions burden on T2� or 
FLAIR, whereas this lesions burden was corre­
lated with the outcome score. Therefore, MRS 
and conventional MR seem to be complementary. 
The combination of these two techniques may be 
useful. Other people showed that NAA/Cr and 
NAA/all metabolites ratios to be signiﬁcantly 
lower in the medial cortex of patients with TBI 
than in normal controls, whereas the La/Cr and 
La/all metabolites ratios were increased (Marino 
et al., 2007). Both NAA and La ratios correlated 
with GOS score. Data of MRS performed early 
after brain injury are clinically relevant. Increased 
La detected may be, at this stage, a reliable index 
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of injury severity and disease outcome in patients 
with TBI. Cohen et al. (2007) included 20 patients 
in a case-control study with the purpose to 
quantify the global decline of the neuronal marker 
NAA, as well as gray and white matter atrophy 
after mild traumatic brain injury (mTBI). Patients 
with mTBI exhibited, on average, a 12% whole-
brain NAA deﬁcit, which increased with age, as 
compared with the control subjects. Volumetric 
MRI in their patients showed decreased volume 
of gray matter, which, in combination with low 
whole-brain NAA, strongly suggests damage to 
the neurons and their axons. Tollard et al. (2009) 
observed NAA/Cr values at all measurement sites 
to be lowest in group of patients with unfavorable 
outcome (GOS, 1–3), intermediate in patients 
with favorable outcome (GOS, 4–5), and highest 
in control group. They did not ﬁnd correlations 
between metabolic ratios and FA values; in 
particular, the NAA/Cr ratio of the pons was not 
correlated with the infratentorial FA value. 
Interestingly an unfavorable outcome after 1 year 
was predicted with up to 86% sensitivity and 97% 
speciﬁcity when taking into account both DTI and 
MRS values. Sensitivity was 79% and speciﬁcity 
85% with FA only; corresponding values with 
MRS only were 75% and 75%. 
In conclusion, proton MRS should be added to 
morphological MR examinations with minimal 
additional time. It is proved to be useful in 
assessing injury severity, guiding patient care, and 
predicting patient outcome (Table 1). We agree 
with Weiss et al. (2007) that MRS studies in TBI 
patients are heterogeneous in terms of patient 
selection, time from TBI to MRS, voxel location, 
method of outcome assessment, and timing of 
outcome assessment. MRS research suffers from 
disparate acquisition protocols across research 
teams. However, the normal NAA/Cr ratio in 
identical regions is similar across studies and its 
decrease appears to be a reliable index of 
unfavorable outcome. The NAA is shown to 
decrease within a few minutes after TBI and reach 
the trough value within 48 h. Its level remains 
stable within the ﬁrst month after TBI, supporting 
the validity of MRS assessment during the second 
or third week (Holshouser et al., 2006; Signoretti 
et al., 2002). The later evolution of the NAA/Cr 
ratio between 6 weeks and 1 year after TBI is 
more heterogeneous, and NAA levels have been 
shown to decrease or increase. This possible 
variability in NAA levels is a potential limitation 
of this technique. In addition, the use of ratios 
may be problematic in TBI. Cr is assumed to be 
stable in normal brain tissue and used to 
standardize other brain metabolites. However, to 
the best of our knowledge, there is no evidence 
that Cr is invariable in TBI. Indeed, it could be 
affected similarly to the metabolite of interest as 
well (it is suggested to be reduced in hypermeta­
bolic and raised in hypometabolic states; Castillo 
et al., 1996; Wood et al., 2003). This issue is 
important in particular as metabolism may be 
compromised in mTBI (Lewine et al., 1999). To 
minimize the potential negative impact of the 
NAA variability, repeated MRS examination 
during the subacute phase is probably needed 
and the whole-brain NAA estimation would 
improve the MRS yield. Studies have to be 
performed to prove the stability of Cr in TBI. 
Diffusion tensor imaging
DTI may be a valuable biomarker for the severity 
of tissue injury and a predictor for outcome. It 
reveals changes in the WM that are correlated 
with both acute GCS and Rankin scores at 
discharge (Huisman et al., 2004). Signiﬁcant early 
reduction of anisotropy was observed in WM 
structures, in particular in the internal capsule and 
the corpus callosum, which are the sites most 
commonly involved by DAI (Arfanakis et al., 
2002). Moreover, several regions recovered nor­
mal values of anisotropy 1 month after the injury 
(Arfanakis et al., 2002). Xu et al. (2007) found 
signiﬁcant differences in the corpus callosum, 
internal and external capsule, superior and 
inferior longitudinal fascicles, and the fornix in 
TBI patients. They showed that FA and ADC 
measurements offered superior sensitivity com­
pared to conventional MRI diagnosis of DAI. 
Salmond et al. (2006) reported increased diffusiv­
ity in TBI patients at least 6 months after their 
injury in the cerebellum, frontal, insula, cingulate, 
parietal, temporal, and occipital lobes. 
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The anisotropy seems to be reduced both in the 
major WM tracts such as the corpus callosum and 
the internal and external capsule, and the 
associative ﬁbers underlying the cortex. DTI has 
a number of advantages as an imaging biomarker 
of brain injury: ﬁrst, it can be used to evaluate 
brain trauma in an unconscious or sedated 
patient; second, it could permit the evaluation of 
responses to treatment even when the clinical 
scores are inadequate for assessing the patient; 
third, quantitative DTI measurements are unli­
kely to be tainted by adverse central nervous 
system (CNS) effects of hypnotic drugs, unlike 
clinical scores; and fourth, DTI may be an 
important alternative marker, as low initial GCS 
scores are of limited value in predicting the 
prognosis (Huisman et al., 2004). Finally, Perlbarg 
et al. (2009) showed signiﬁcant FA differences 
between favorable and unfavorable 1-year out­
come groups around four FA tracks: in inferior 
longitudinal fasciculus, posterior limb of the 
internal capsule, cerebral peduncle, and posterior 
corpus callosum. 
Conclusion
In the future, DTI and MRS may permit to 
evaluate response to therapeutic interventions in 
TBI even when the clinical scores are inadequate 
for assessing the patient. MRS and DTI detect 
abnormalities not demonstrated on conventional 
MRI or CT structural scans, which are generally 
correlated with clinical outcomes. It is becoming 
increasingly obvious that these techniques are 
complementary and that both could be required 
to explore comatose patients at subacute stage 
from TBI as part of a comprehensive multimodal 
MRI and clinical assessment. Their combination 
will also possibly allow the pathogenesis of 
brain impairment to be better understood and 
the outcome better predicted. However, it is 
important to keep in mind some pitfalls such as 
the variability of NAA values and the impact of 
brain swelling which can, respectively, diminish 
the reliability of NAA and early FA measurement 
for predicting outcome in individual brain-
damaged patients. 
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